Measuring liver blood flow during embolization
Part of Cancer clinical trials.
This study measures blood flow in the liver during a procedure called transarterial embolization, which blocks blood vessels to treat tumors. It may help doctors understand how to better plan treatments for liver conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be willing to give your written permission to join the study.
- You must follow the study's schedule and procedures.
- You cannot be pregnant or breastfeeding.
- You cannot have advanced kidney disease (stage 4 or 5) unless you are on dialysis and not expected to recover.
- You cannot have a severe allergy to iodine dye that cannot be treated in advance.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with liver cancer (hepatocellular carcinoma) who are about to receive a type of internal radiation therapy called TARE (also known as radioembolization). Researchers want to learn more about how the cancer responds to this treatment using scans and biopsies. You might be a good fit if you have not had any prior treatment for your liver cancer.
This study measures how blood flow responds after a non-surgical energy test. It is likely looking for normal, healthy blood-flow reactions and how different people respond.
This study is testing a way to closely monitor blood flow and pressure during liver transplant surgery to help improve safety and outcomes. It may help patients undergoing a liver transplant.
This trial uses a special ultrasound with a contrast agent to see how well a liver cancer treatment called TACE is working. It may help doctors better understand if the treatment is shrinking the tumor.
This study looks at a new way to monitor blood flow in tiny blood vessels during liver transplant surgery. It may help doctors better understand how well blood is reaching tissues during the operation.
This trial tests a procedure called splenic artery embolization (blocking part of the blood supply to the spleen) to reduce belly fluid buildup in people with advanced liver disease. It may help if your ascites has not improved with standard treatments and you are not a candidate for TIPS.
Hear when a new Transarterial Chemoembolization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.